Cost analysis of implementing mHealth intervention for maternal, newborn & child health care through community health workers: assessment of ReMIND program in Uttar Pradesh, India

Abstract

BackgroundThe main intervention under ReMiND program consisted of a mobile health application which was used by community health volunteers, called ASHAs, for counselling pregnant women and nursing mothers. This program was implemented in two rural blocks in Uttar Pradesh state of India with an overall aim to increase quality of health care, thereby increasing utilization of maternal & child health services. The aim of the study was to assess annual & unit cost of ReMiND program and its scale up in UP state.Method and materialsEconomic costing was done from the health system and patient’s perspectives. All resources used during designing & planning phase i.e., development of application; and implementation of the intervention, were quantified and valued. Capital costs were annualised, after assessing their average number of years for which a product could be used and accounting for its depreciation. Shared or joint costs were apportioned for the time value a resource was utilized under intervention. Annual cost of implementing ReMiND in two blocks of UP along and unit cost per pregnant woman were estimated. Scale-up cost for implementing the intervention in entire state was calculated under two scenarios – first, if no extra human resource were employed; and second, if the state government adopted the same pattern of human resource as employed under this program.ResultsThe annual cost for rolling out ReMiND in two blocks of district Kaushambi was INR 12.1 million (US $ 191,894). The annualised start-up cost constituted 9% of overall cost while rest of cost was attributed to implementation of the intervention. The health system program costs in ReMiND were estimated to be INR 31.4 (US $ 0.49) per capita per year and INR 1294 (US $ 20.5) per registered women. The per capita incremental cost of scale up of intervention in UP state was estimated to be INR 4.39 (US $ 0.07) when no additional supervisory staffs were added.ConclusionThe cost of scale up of ReMiND in Uttar Pradesh is 6% of annual budget for ‘reproductive and child health’ line item under state budget, and hence appears to be financially sustainable.Electronic supplementary materialThe online version of this article (10.1186/s12884-018-2019-3) contains supplementary material, which is available to authorized users.

The use of mobile phones for the prevention and control of arboviral diseases: a scoping review

“…computers, software developers) [ 26 ]. However, mHealth programmes have reported to be sustainable in the management of other diseases [ 110 ]. Further outcome dimensions need to be evaluated that go beyond the performance of the mobile phone in order to understand their real impact on arboviruses.…”

The Use of Mobile Phones for the Prevention and Control of Arboviral Diseases: A Scoping Review

“…Our results must be considered with caution, given the scarcity of information related to this outcome. However, positive cost outcomes using mHealth interventions in other diseases have been con rmed in various studies (Prinja et al, 2018;Iribarren et al 2017). Further studies are needed in order to better understand their economic bene t for the prevention and control of arboviral diseases.…”

Cost-Effectiveness of Therapeutic Use of Safety-Engineered Syringes in Healthcare Facilities in India

“…This was done in view of the fact that the risk of transmission of BBIs is dependent on the route of administration. An extensive review of the literature was undertaken to obtain data on the extent and patterns of the healthcare workforce [42] (Supplementary Appendix, Section D, Table 1), morbidity rate, treatment-seeking behaviours and patterns of care utilization [32], frequency of injections [3], route of administration [43], treatment by different healthcare professionals [44], risk of NSI using a disposable syringe [44,45], syringe reuse rates [45,46], prevalence of HBV, HCV and HIV [47][48][49][50], risk-transmission coefficient as a result of NSI or reuse [51], and all-cause mortality rates [52]. We have assumed a wide uncertainty range for transmission coefficients as there is a scarcity of reliable data in the Indian setting on the risk of HIV transmission per sex act.…”

“…In situations where the rates were available for a longer time period, we assumed uniform progression during intervening cycles. Year-wise all-cause mortality rates obtained from Sample Registration System (SRS) life tables were used [52].…”